Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TripleTree is a healthcare-focused investment bank and advisory firm that provides mergers and acquisitions, recapitalization, growth capital, and strategic advisory services to healthcare technology, healthcare services, and pharma services and technology companies. Founded in 1997 in Minnesota, the firm built a longstanding specialization in advising innovative and growth-oriented healthcare businesses. In November 2021, Capital One completed the acquisition of TripleTree, and the business now operates under the TripleTree brand within Capital One Commercial Bank’s Capital Markets group. TripleTree is not a drug developer; its core business is transaction advisory and investment banking for the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TripleTree Holdings.